1093.HK vs. 1810.HK
1093.HK (CSPC Pharmaceutical Group Ltd) and 1810.HK (Xiaomi Corp) are both stocks. 1093.HK operates in Drug Manufacturers - General (Healthcare), while 1810.HK operates in Consumer Electronics (Technology). Over the past 5 years, 1093.HK returned -7.56%/yr vs -1.43%/yr for 1810.HK. At a 0.39 correlation, their price movements are largely independent.
Performance
1093.HK vs. 1810.HK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 1093.HK achieves a -14.12% return, which is significantly higher than 1810.HK's -33.33% return.
1093.HK
- 1D
- 0.42%
- 1M
- -10.06%
- YTD
- -14.12%
- 6M
- -5.48%
- 1Y
- -18.77%
- 3Y*
- 6.09%
- 5Y*
- -7.56%
- 10Y*
- 17.71%
1810.HK
- 1D
- 1.39%
- 1M
- -17.61%
- YTD
- -33.33%
- 6M
- -39.01%
- 1Y
- -49.81%
- 3Y*
- 33.79%
- 5Y*
- -1.43%
- 10Y*
- —
1093.HK vs. 1810.HK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
1093.HK CSPC Pharmaceutical Group Ltd | -14.12% | 81.38% | -30.97% | -7.80% | -0.70% | 8.57% | 61.50% | 68.76% | -48.38% |
1810.HK Xiaomi Corp | -33.33% | 13.91% | 121.15% | 42.60% | -42.12% | -42.81% | 206.59% | -16.56% | -22.17% |
Correlation
The correlation between 1093.HK and 1810.HK is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.34 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (All Time) Calculated using the full available price history since Jul 9, 2018 | 0.39 |
The correlation between 1093.HK and 1810.HK shifts across timeframes, from 0.20 (1 year) to 0.39 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
1093.HK vs. 1810.HK — Risk / Return Rank
1093.HK
1810.HK
1093.HK vs. 1810.HK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CSPC Pharmaceutical Group Ltd (1093.HK) and Xiaomi Corp (1810.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| 1093.HK | 1810.HK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.05 | ||
| Sortino ratioReturn per unit of downside risk | +2.10 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.74 | +0.23 |
| Calmar ratioReturn relative to maximum drawdown | -0.50 | -0.89 | +0.39 |
| Martin ratioReturn relative to average drawdown | -0.89 | -1.51 | +0.61 |
Loading charts...
Drawdowns
1093.HK vs. 1810.HK - Drawdown Comparison
The maximum 1093.HK drawdown since its inception was -74.77%, roughly equal to the maximum 1810.HK drawdown of -76.06%. Use the drawdown chart below to compare losses from any high point for 1093.HK and 1810.HK.
Loading charts...
Drawdown Indicators
| 1093.HK | 1810.HK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.77% | -76.06% | +1.29% |
Max Drawdown (1Y)Largest decline over 1 year | -38.44% | -57.04% | +18.60% |
Max Drawdown (3Y)Largest decline over 3 years | -38.44% | -57.04% | +18.60% |
Max Drawdown (5Y)Largest decline over 5 years | -60.67% | -70.66% | +9.99% |
Max Drawdown (10Y)Largest decline over 10 years | -61.30% | — | — |
Current DrawdownCurrent decline from peak | -35.97% | -56.44% | +20.47% |
Average DrawdownAverage peak-to-trough decline | -26.54% | -42.06% | +15.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.32% | 33.21% | -11.89% |
Volatility
1093.HK vs. 1810.HK - Volatility Comparison
CSPC Pharmaceutical Group Ltd (1093.HK) has a higher volatility of 13.44% compared to Xiaomi Corp (1810.HK) at 9.01%. This indicates that 1093.HK's price experiences larger fluctuations and is considered to be riskier than 1810.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 1093.HK | 1810.HK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.44% | 9.01% | +4.43% |
Volatility (6M)Calculated over the trailing 6-month period | 35.31% | 26.27% | +9.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.52% | 35.47% | +15.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.72% | 44.12% | +0.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 47.08% | 45.76% | +1.32% |
Dividends
1093.HK vs. 1810.HK - Dividend Comparison
1093.HK's dividend yield for the trailing twelve months is around 1.93%, while 1810.HK has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1093.HK CSPC Pharmaceutical Group Ltd | 1.93% | 2.85% | 6.28% | 3.44% | 2.44% | 2.01% | 1.79% | 1.86% | 2.55% | 1.46% | 2.55% | 2.43% |
1810.HK Xiaomi Corp | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
1093.HK vs. 1810.HK - Financials Comparison
This section allows you to compare key financial metrics between CSPC Pharmaceutical Group Ltd and Xiaomi Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
1093.HK and 1810.HK have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for 1093.HK and 1810.HK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer